“Problems of Innovation-Deficient Pharmaceutical Manufacturing”
Nicholson Price- AI, Law, and Technology
- Health Law
New England Journal of Medicine
2013
“Unblocked Future: Why Gene Patents Won’t Hinder Whole-Genome Sequencing and Personalized Medicine”
Nicholson Price- AI, Law, and Technology
- Health Law
Cardozo Law Review
2012
“Large-Scale Experimental Studies Show Unexpected Amino Acid Effects on Protein Expression and Solubility in Vivo in E. coli”
Nicholson Price- AI, Law, and Technology
- Health Law
Microbial Informatics and Experimentation
2011
“Am I My Son? Human Clones and the Modern Family”
Nicholson Price- AI, Law, and Technology
- Health Law
Columbia Science and Technology Law Review
2010
“The Deepwater Horizon Oil Spill: Potential Insurance Coverage Implications”
Nicholson Price- AI, Law, and Technology
- Health Law
Insurance Coverage Law Bulletin
2010
“Understanding the Physical Properties that Control Protein Crystallization by Analysis of Large-Sale Experimental Data”
Nicholson Price- AI, Law, and Technology
- Health Law
Nature Biotechnology
2009
“MxA Gene Expression Analysis as an Interferon-beta Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity”
Nicholson Price- AI, Law, and Technology
- Health Law
Molecular Diagnosis
2003
“Uncorrected”
Nicholson Price
Boston University Law Review
“Monitoring, Oversight, and Learning in Medical AI”
Nicholson Price
Columbia Science & Technology Law Review
“Secrecy, Health Data Infrastructure, and Medical AI”
Nicholson Price
Research Handbook on Trade Secrecy in Data and Data Infrastructure
“An Incidental Standard for Medical AI”
Nicholson Price- AI, Law, and Technology
Journal of Law and Innovation